Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04200378 · ClinicalTrials.gov registry record
Invasive Hemodynamic Response to Transcatheter Edge-to-Edge Mitral Valve Repair
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 22
- Enrollment target
NCT04200378: Completed study, sponsored by Mayo Clinic.
NCT04200378 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04200378 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Studying the effects of Trans-catheter Mitral Valve Repair (TMVr) on the hemodynamics and biomarkers in patients with severe mitral valve regurgitation.
Primary Outcome
Change in stroke volume index 10 minutes post repair to baseline stroke volume index measurement (L/m\^2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2024-04-11 |
What the finished NCT04200378 record still lists
NCT04200378 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04200378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04200378 about?
NCT04200378 is a clinical study titled "Invasive Hemodynamic Response to Transcatheter Edge-to-Edge Mitral Valve Repair". Studying the effects of Trans-catheter Mitral Valve Repair (TMVr) on the hemodynamics and biomarkers in patients with severe mitral valve regurgitation.
What is the current status of trial NCT04200378?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2020-08-20. Estimated completion is 2024-04-11.
Who is sponsoring clinical trial NCT04200378?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI